SG11201403265VA - Medical composition for preventing or treating amyloid β peptide related diseases or conditions - Google Patents
Medical composition for preventing or treating amyloid β peptide related diseases or conditionsInfo
- Publication number
- SG11201403265VA SG11201403265VA SG11201403265VA SG11201403265VA SG11201403265VA SG 11201403265V A SG11201403265V A SG 11201403265VA SG 11201403265V A SG11201403265V A SG 11201403265VA SG 11201403265V A SG11201403265V A SG 11201403265VA SG 11201403265V A SG11201403265V A SG 11201403265VA
- Authority
- SG
- Singapore
- Prior art keywords
- preventing
- conditions
- related diseases
- medical composition
- peptide related
- Prior art date
Links
- 102000013455 Amyloid beta-Peptides Human genes 0.000 title 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/10—Chewing gum characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161576367P | 2011-12-16 | 2011-12-16 | |
| PCT/CN2012/086796 WO2013087042A1 (zh) | 2011-12-16 | 2012-12-17 | 预防或治疗淀粉样β肽相关疾病或状况的医药组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201403265VA true SG11201403265VA (en) | 2014-09-26 |
Family
ID=48580733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201403265VA SG11201403265VA (en) | 2011-12-16 | 2012-12-17 | Medical composition for preventing or treating amyloid β peptide related diseases or conditions |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150087606A1 (enExample) |
| EP (1) | EP2792361B1 (enExample) |
| JP (1) | JP6134331B2 (enExample) |
| KR (1) | KR102048289B1 (enExample) |
| CN (1) | CN103156867B (enExample) |
| AU (1) | AU2012350437B2 (enExample) |
| CA (1) | CA2859227C (enExample) |
| MY (1) | MY171048A (enExample) |
| SG (1) | SG11201403265VA (enExample) |
| TW (1) | TWI488630B (enExample) |
| WO (1) | WO2013087042A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150291645A1 (en) * | 2014-04-10 | 2015-10-15 | Sinphar Pharmaceutical Co., Ltd. | Isoacteoside derivative and use thereof |
| TWI650131B (zh) * | 2014-07-03 | 2019-02-11 | 杏輝藥品工業股份有限公司 | 管花肉蓯蓉萃取物之用於製備保護眼部細胞之藥品或食品用途 |
| CN104922137B (zh) * | 2015-06-04 | 2018-07-31 | 苏州大学 | 苯乙醇苷类化合物Torenoside B的新用途 |
| KR102018085B1 (ko) * | 2017-12-06 | 2019-09-04 | 김좌진 | 악테오사이드를 함유하는 뇌종양 치료 및 전이 억제용 약학 조성물 |
| KR102135148B1 (ko) * | 2019-08-28 | 2020-07-20 | 김좌진 | 악테오사이드를 함유하는 뇌종양 치료 및 전이 억제용 약학 조성물 |
| CN110812375A (zh) * | 2019-12-12 | 2020-02-21 | 中国海洋大学 | 一种老鼠簕中苯乙醇苷类提取物及其制备方法与作为抗肝损伤药物的应用 |
| CN111632058A (zh) * | 2020-06-24 | 2020-09-08 | 新疆医科大学 | 毛蕊花糖苷在制备预防和治疗神经退行性疾病药物中的应用 |
| CN112225766A (zh) * | 2020-10-27 | 2021-01-15 | 杏辉天力（杭州）药业有限公司 | 一种由肉苁蓉萃取物中富集及分离苯乙醇苷类化合物的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100500584B1 (ko) * | 2002-08-12 | 2005-07-12 | 경희대학교 산학협력단 | 신경성장인자와 유사 작용을 갖는 육종용 추출물 및 이를함유하는 조성물 |
| KR100514076B1 (ko) * | 2003-01-10 | 2005-09-13 | 주식회사 엘컴사이언스 | 페닐에타노이드 유도체를 포함하는 퇴행성 뇌신경계질환의 예방 및 치료용 조성물 |
| TW200416036A (en) * | 2003-02-18 | 2004-09-01 | Sinphar Pharmaceutical Co Ltd | Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same |
| CN1268341C (zh) * | 2003-03-04 | 2006-08-09 | 杏辉天力（杭州）药业有限公司 | 来源于管花肉苁蓉的含有苯乙醇苷的制剂及其制备方法和用途 |
| CN100345857C (zh) * | 2004-07-16 | 2007-10-31 | 北京华医神农医药科技有限公司 | 一种从肉苁蓉药材中提取、分离松果菊苷的方法 |
| EP1736167B1 (en) * | 2005-06-20 | 2018-03-21 | I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. | Extracts obtained from cell line cultures from Syringa vulgaris IRB-SV25/B (DMS:16857), their preparation and use |
| JP5410683B2 (ja) * | 2008-02-19 | 2014-02-05 | 学校法人近畿大学 | カンカニクジュヨウから得られる肝保護剤及び抗ＴＮＦ−α作用剤 |
| CN101411753B (zh) * | 2008-12-04 | 2012-02-29 | 闫明 | 列当总苷在制备抗老年痴呆的药物中的应用 |
| CN101797307B (zh) * | 2010-04-09 | 2011-08-10 | 广州中医药大学 | 一种含苯乙醇苷的枇杷叶紫珠提取物及其制备方法 |
| TWI486162B (zh) * | 2010-06-16 | 2015-06-01 | Sinphar Pharmaceutical Co Ltd | 異類葉升麻苷或其醫藥學上可接受之鹽於抑制澱粉樣β肽生成、累積或聚集、以及製備預防或治療澱粉樣β肽相關疾病或狀況的藥物之用途 |
| CN102670631B (zh) * | 2011-12-01 | 2013-07-31 | 河南科技大学 | 一种四楞麻总苯乙醇苷组合物、制备方法及应用 |
-
2012
- 2012-12-17 CN CN201210548516.0A patent/CN103156867B/zh active Active
- 2012-12-17 CA CA2859227A patent/CA2859227C/en active Active
- 2012-12-17 EP EP12856624.7A patent/EP2792361B1/en active Active
- 2012-12-17 JP JP2014546303A patent/JP6134331B2/ja active Active
- 2012-12-17 US US14/365,404 patent/US20150087606A1/en not_active Abandoned
- 2012-12-17 TW TW101147781A patent/TWI488630B/zh active
- 2012-12-17 KR KR1020147018051A patent/KR102048289B1/ko active Active
- 2012-12-17 MY MYPI2014001777A patent/MY171048A/en unknown
- 2012-12-17 WO PCT/CN2012/086796 patent/WO2013087042A1/zh not_active Ceased
- 2012-12-17 AU AU2012350437A patent/AU2012350437B2/en active Active
- 2012-12-17 SG SG11201403265VA patent/SG11201403265VA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013087042A1 (zh) | 2013-06-20 |
| CA2859227C (en) | 2019-01-22 |
| TWI488630B (zh) | 2015-06-21 |
| CN103156867B (zh) | 2019-04-30 |
| MY171048A (en) | 2019-09-23 |
| EP2792361A1 (en) | 2014-10-22 |
| AU2012350437B2 (en) | 2017-06-29 |
| JP6134331B2 (ja) | 2017-05-24 |
| EP2792361B1 (en) | 2019-03-27 |
| TW201325597A (zh) | 2013-07-01 |
| CA2859227A1 (en) | 2013-06-20 |
| EP2792361A4 (en) | 2015-05-13 |
| CN103156867A (zh) | 2013-06-19 |
| KR102048289B1 (ko) | 2020-01-08 |
| AU2012350437A1 (en) | 2014-07-31 |
| KR20150002576A (ko) | 2015-01-07 |
| JP2015500300A (ja) | 2015-01-05 |
| US20150087606A1 (en) | 2015-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201207613B (en) | Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins | |
| ZA201402424B (en) | 1- arylcarbonyl -4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases | |
| PL2643004T3 (pl) | Kompozycja oligosacharydów do leczenia chorób skóry | |
| GB201021103D0 (en) | New compounds for the treatment of neurodegenerative diseases | |
| PT2740793T (pt) | Composição de fármacos para o tratamento e/ou a prevenção de cancro | |
| IL231836A0 (en) | The vehicle for treating the siege | |
| EP2611765A4 (en) | METHODS OF TREATING NEURODEGENERATIVE DISEASES | |
| SG11201403265VA (en) | Medical composition for preventing or treating amyloid β peptide related diseases or conditions | |
| EP2906583A4 (en) | PEPTIDES FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
| ZA201501390B (en) | Compounds for the treatment of mtor pathway related diseases | |
| BR112014004416A2 (pt) | composições e métodos para o tratamento de doenças neurodegenerativas | |
| IL231157A0 (en) | Preparations and methods for the treatment of neurodegenerative diseases | |
| IL241253A0 (en) | Peptides for the treatment of neurodegenerative diseases | |
| PL2604264T3 (pl) | Kompozycja farmaceutyczna do leczenia chorób wirusowych | |
| HUP1100290A2 (en) | Combination compositions for the treatment of proliferative diseases | |
| IL234796B (en) | Compounds for the treatment of diseases related to ischemia-reperfusion | |
| PL2768527T3 (pl) | Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1 | |
| EP2785342A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPERTRIGLYCERIDEMIA OR DISEASES ASSOCIATED WITH HYPERTRIGLYCERIDEMIA | |
| HUP1100245A2 (en) | Pharmaceutical composition for the treatment of wounds | |
| GB201110659D0 (en) | composition for skin treatment | |
| GB201110653D0 (en) | Composition for skin treatment | |
| AU2012901597A0 (en) | A Pharmaceutical Composition and Method for Treating or Preventing Beta Amyloid Diseases | |
| AU2012901596A0 (en) | A Pharmaceutical Composition and Method for Treating or Preventing Beta Amyloid Diseases | |
| AU2011901481A0 (en) | A Pharmaceutical Composition and Method for Treating or Preventing Beta Amyloid Diseases | |
| AU2011901485A0 (en) | A Pharmaceutical Composition and Method for Treating or Preventing Beta Amyloid Diseases |